DEPACON

LOE Approaching

valproate sodium

AbbVie
NDAINJECTIONINJECTABLE
Approved
Dec 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

blood. The mechanisms by which valproate exerts its therapeutic effects have not been established. It has been suggested that its activity in epilepsy is related to increased brain concentrations of gamma-aminobutyric acid (GABA).

Indications (7)

womenwomen of childbearing potentialEpilepsymigrainebipolar disorderwomen with epilepsyplan to become pregnant unless other medications have failed to provide adequate symptom control

Clinical Trials (1)

NCT00203242N/ACompleted

An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches.

Started Jul 2003
15 enrolled
Cluster Headache
Company
AbbVie
AbbVie
NORTH CHICAGO, IL
1495 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers